Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by plantraderon May 15, 2024 2:44pm
169 Views
Post# 36041699

RE:RE:RE:RE:RE:RE:Keep patient, maybe we are at last step to the final victory

RE:RE:RE:RE:RE:RE:Keep patient, maybe we are at last step to the final victoryN0t, I have to agree. I understand and would theorize that there are much more important issues that we probably aren't aware of. But still, it's not very difficult to be clear is it? And to keep in mind that when you change timelines repeatedly and/or other milestones aren't accomplished for notable periods of time (enrollment?) then naturally most everyone would like to know why. Unless I'm remembering wrong, I believe Dr Mandel said in an interview in late 2022 that BTD application was expected in Jan 2023? Wasn't he interim CEO at the time? About a year and half later we are still wondering which timeline will stick w/out much info as to why. Also did we get any explanation about why enrollment had apparently slowed to a crawl quite a while ago? Those are just examples for why some frustration about clear communication might be understandable. Objectivity.

Unless the actual reasons are unpleasant and would create negative sentiment, in which case maybe they decide not to explain themselves because it could open a can of worms that they don't deem necessary or beneficial? Otherwise why leave everyone guessing? Aside from possibly not wanting shareholders to be privy to dirty laundry (which explanations might expose), they might also not want competition to know specifically what their weaknesses or issues are? Shareholders are stuck guessing. Would be nice for everyone if one of the rose colored theories could come true someday.
<< Previous
Bullboard Posts
Next >>